Download the Presentations


Integrated Symposium at ECCMID 2019
Monday, April 15th 2019

Rapid Diagnostics Direct from Whole Blood: A Solution for Fast and Appropriate Antimicrobial Therapy

Sepsis in the non-neutropenic host – Is there a need for molecular testing?
Prof. Michael Bauer, MD Jena University, Jena, Germany

Incorporating direct from whole blood diagnostics into clinical and antimicrobial stewardship practices
Dr. Cornelius (Neil) Clancy, University of Pittsburgh Medical Center, Pittsburgh, United States

Clinical experience with a bacteria panel and resistance markers direct from whole blood
Dr. Giulia De Angelis, Institute of Microbiology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy

T2MR improves patient outcomes and guides therapy decisions in immunocompromised patients
Dr. Thomas Walsh, New York Presbyterian Hospital, New York City, United States